Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial

por Zhao, Qiuling, Xie, Ruixiang, Zhong, Wanfu, Liu, Wenbin, Chen, Ting, Qiu, Xiuliang, Yang, Lin
Publicado 2023